Literature DB >> 19850138

Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection".

H Diana Rosas1, Stephanie Y Lee, Alexander C Bender, Alexandra K Zaleta, Mark Vangel, Peng Yu, Bruce Fischl, Vasanth Pappu, Christina Onorato, Jang-Ho Cha, David H Salat, Steven M Hersch.   

Abstract

The corpus callosum (CC) is the major conduit for information transfer between the cerebral hemispheres and plays an integral role in relaying sensory, motor and cognitive information between homologous cortical regions. The majority of fibers that make up the CC arise from large pyramidal neurons in layers III and V, which project contra-laterally. These neurons degenerate in Huntington's disease (HD) in a topographically and temporally selective way. Since any focus of cortical degeneration could be expected to secondarily de-afferent homologous regions of cortex, we hypothesized that regionally selective cortical degeneration would be reflected in regionally selective degeneration of the CC. We used conventional T1-weighted, diffusion tensor imaging (DTI), and a modified corpus callosum segmentation scheme to examine the CC in healthy controls, huntingtin gene-carriers and symptomatic HD subjects. We measured mid-sagittal callosal cross-sectional thickness and several DTI parameters, including fractional anisotropy (FA), which reflects the degree of white matter organization, radial diffusivity, a suggested index of myelin integrity, and axial diffusivity, a suggested index of axonal damage of the CC. We found a topologically selective pattern of alterations in these measures in pre-manifest subjects that were more extensive in early symptomatic HD subjects and that correlated with performance on distinct cognitive measures, suggesting an important role for disrupted inter-hemispheric transfer in the clinical symptoms of HD. Our findings provide evidence for early degeneration of commissural pyramidal neurons in the neocortex, loss of cortico-cortical connectivity, and functional compromise of associative cortical processing. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19850138      PMCID: PMC3725957          DOI: 10.1016/j.neuroimage.2009.10.015

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  50 in total

1.  White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease.

Authors:  Stefan Klöppel; Bogdan Draganski; Charlotte V Golding; Carlton Chu; Zoltan Nagy; Philip A Cook; Stephen L Hicks; Christopher Kennard; Daniel C Alexander; Geoff J M Parker; Sarah J Tabrizi; Richard S J Frackowiak
Journal:  Brain       Date:  2007-12-03       Impact factor: 13.501

2.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

Review 3.  Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Nathanael Hevelone; Steven M Hersch
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 4.  Simultaneous inference in general parametric models.

Authors:  Torsten Hothorn; Frank Bretz; Peter Westfall
Journal:  Biom J       Date:  2008-06       Impact factor: 2.207

Review 5.  Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.

Authors:  Susan E Browne
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

6.  Toward accurate diagnosis of white matter pathology using diffusion tensor imaging.

Authors:  Matthew D Budde; Joong Hee Kim; Hsiao-Fang Liang; Robert E Schmidt; John H Russell; Anne H Cross; Sheng-Kwei Song
Journal:  Magn Reson Med       Date:  2007-04       Impact factor: 4.668

7.  Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis.

Authors:  N H Stricker; B C Schweinsburg; L Delano-Wood; C E Wierenga; K J Bangen; K Y Haaland; L R Frank; D P Salmon; M W Bondi
Journal:  Neuroimage       Date:  2008-12-06       Impact factor: 6.556

8.  Longitudinal diffusion tensor imaging in Huntington's Disease.

Authors:  Kurt E Weaver; Todd L Richards; Olivia Liang; Mercy Y Laurino; Ali Samii; Elizabeth H Aylward
Journal:  Exp Neurol       Date:  2009-04       Impact factor: 5.330

9.  In vivo evidence for the selective subcortical degeneration in Huntington's disease.

Authors:  Gwenaëlle Douaud; Timothy E Behrens; Cyril Poupon; Yann Cointepas; Saâd Jbabdi; Véronique Gaura; Narly Golestani; Pierre Krystkowiak; Christophe Verny; Philippe Damier; Anne-Catherine Bachoud-Lévi; Philippe Hantraye; Philippe Remy
Journal:  Neuroimage       Date:  2009-03-28       Impact factor: 6.556

10.  Measuring fractional anisotropy of the corpus callosum using diffusion tensor imaging: mid-sagittal versus axial imaging planes.

Authors:  Eung Yeop Kim; Hae-Jeong Park; Dong-Hyun Kim; Seung-Koo Lee; Jinna Kim
Journal:  Korean J Radiol       Date:  2008 Sep-Oct       Impact factor: 3.500

View more
  105 in total

1.  Dynamic changes of ICA-derived EEG functional connectivity in the resting state.

Authors:  Jean-Lon Chen; Tomas Ros; John H Gruzelier
Journal:  Hum Brain Mapp       Date:  2012-02-17       Impact factor: 5.038

2.  Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain.

Authors:  Alexandre Kuhn; Doris Thu; Henry J Waldvogel; Richard L M Faull; Ruth Luthi-Carter
Journal:  Nat Methods       Date:  2011-10-09       Impact factor: 28.547

Review 3.  Huntington's disease: progress toward effective disease-modifying treatments and a cure.

Authors:  Carl D Johnson; Beverly L Davidson
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

Review 4.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 5.  Polyglutamine toxicity in non-neuronal cells.

Authors:  Jennifer W Bradford; Shihua Li; Xiao-Jiang Li
Journal:  Cell Res       Date:  2010-03-16       Impact factor: 25.617

6.  Key role of nuclear medicine in seeking biomarkers of Huntington's disease.

Authors:  Ferdinando Squitieri; Andrea Ciarmiello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06       Impact factor: 9.236

7.  Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's disease.

Authors:  Hans-Peter Müller; Sigurd D Süssmuth; G Bernhard Landwehrmeyer; Albert Ludolph; Sarah J Tabrizi; Stefan Kloppel; Jan Kassubek
Journal:  PLoS Curr       Date:  2011-12-12

8.  Joint reconstruction of white-matter pathways from longitudinal diffusion MRI data with anatomical priors.

Authors:  Anastasia Yendiki; Martin Reuter; Paul Wilkens; H Diana Rosas; Bruce Fischl
Journal:  Neuroimage       Date:  2015-12-21       Impact factor: 6.556

Review 9.  The evolving role of diffusion magnetic resonance imaging in movement disorders.

Authors:  Christopher W Hess; Edward Ofori; Umer Akbar; Michael S Okun; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

10.  Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease.

Authors:  Deborah L Harrington; Jeffrey D Long; Sally Durgerian; Lyla Mourany; Katherine Koenig; Aaron Bonner-Jackson; Jane S Paulsen; Stephen M Rao
Journal:  Mov Disord       Date:  2016-09-13       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.